Clinical Study

Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients

Table 3

Biochemical parameters and inflammatory markers (hs-CRP and IL-6) in the three groups of kidney transplant recipients (NW: normal weight, OW: overweight, OB: obese).

NW
OW
OB

eGFR° (mL/min)50.8 ± 19.454.1 ± 13.263.0 ± 25.2
Plasma glucose (mg/dL)77.7 ± 9.181.3 ± 15.082.9 ± 17.6
Plasma total cholesterol (mg/dL)188.9 ± 33.5181.0 ± 25.2185.9 ± 31.4
Plasma HDL cholesterol (mg/dL)49.4 ± 11.755.0 ± 14.950.0 ± 19.5
Plasma LDL cholesterol (mg/dL)107.5 ± 34.996.3 ± 19.9105.4 ± 30.4
Plasma tryglycerides (mg/dL)153.5 ± 74.2157.0 ± 46.8154.3 ± 63.0
Serum uric acid6.2 ± 0.76.3 ± 1.15.9 ± 1.0
Calcium (mg/dL)9.7 ± 0.59.9 ± 0.49.6 ± 0.2
Phosphorus (mg/dL)3.4 ± 0.83.2 ± 0.43.3 ± 0.4
Albumin (g/dL)4.4 ± 0.34.5 ± 0.24.5 ± 0.3
hs-CRP (mg/L) 2.7 ± 2.44.0 ± 3.74.8 ± 3.9*
IL-6 (pg/mL)4.5 ± 3.25.0 ± 4.47.3 ± 5.0*
Fibrinogen (mg/dL)377.1 ± 123.4326.0 ± 45.7372.9 ± 101.1

Glomerular filtration rate (expressed by MDRD formula).
* versus NW.